Follicular thyroid cancer with sternal metastasis - challenges and outcomes.

Med J Malaysia

Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Department of Surgery, Plastics and Reconstructive Unit, 56000 Cheras, Kuala Lumpur, Malaysia.

Published: February 2017

Sternal metastasis from differentiated thyroid carcinoma (DTC) is rare and presents a conundrum for surgeons. We present a lady diagnosed with follicular thyroid carcinoma and sternal metastasis who underwent thyroidectomy, sternectomy and sternoplasty with titanium mesh and acrylic plate. She developed a surgical site infection, of which multiple conservative approaches were attempted. She eventually required removal of the implant. Closure of sternal defect was completed with bilateral pectoralis major advancement flaps. This article highlights a series of complications faced during the course of treatment and how they were managed in a tertiary healthcare centre.

Download full-text PDF

Source

Publication Analysis

Top Keywords

sternal metastasis
12
follicular thyroid
8
thyroid carcinoma
8
thyroid cancer
4
sternal
4
cancer sternal
4
metastasis challenges
4
challenges outcomes
4
outcomes sternal
4
metastasis differentiated
4

Similar Publications

Long-term Survival in Stage IVb Thymic Carcinoma With Multidisciplinary Aggressive Treatment.

Ann Thorac Surg Short Rep

June 2024

Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Shiga, Japan.

Thymic carcinoma, a rare aggressive tumor, necessitates multidisciplinary approaches for optimal prognosis. The role of surgical interventions in stage IVb thymic carcinoma, as classified by the TNM and Masaoka-Koga staging systems, remains controversial; although some patients present with resectable disease, others do not. We report a case with supraclavicular metastasis and sternal invasion.

View Article and Find Full Text PDF

Background: ()-mutant non-small-cell lung cancers (NSCLCs) have higher frequencies of bone metastases than those of wild type; however, the metastatic pattern and influence on clinical outcome remain unclear.

Objectives: To analyze the association between bone metastatic sites and the clinical efficacy of the first-, second-, and third-generation EGFR-tyrosine kinase inhibitors (TKI), in these patients.

Design: Retrospective multicenter cohort study.

View Article and Find Full Text PDF

The aim of this retrospective multicentric case series is to describe the CT findings of ovarian neoplasia in dogs. Twenty dogs with pre- and postcontrast CT exams and cytological/histological diagnosis of ovarian neoplasia were included. Five dogs presented with bilateral tumors, for a total of 25 neoplasms: 15 carcinomas (4 bilateral), 4 granulosa cell tumors, 2 poorly differentiated malignant neoplasia (bilateral), 2 luteomas, 1 teratoma, 1 dysgerminoma.

View Article and Find Full Text PDF

Hidradenocarcinoma (HAC) is a rare malignant neoplasm originating from eccrine sweat glands, often presenting diagnostic challenges because of its resemblance to other malignancies, particularly breast cancer when occurring in the chest region. This report describes 2 cases of HAC with axillary lymph node metastasis, both initially misinterpreted clinically. The first case involved a 63-year-old woman with a sternal mass, near the right breast, initially suspected to be a sebaceous cyst.

View Article and Find Full Text PDF
Article Synopsis
  • * Neoplastic fever (NF) is a rare fever associated with malignant tumors, and in this case, it presented in an unusual manner in a patient with UPS who had refractory fever and systemic inflammation.
  • * A 58-year-old male patient with UPS-NF had a history of fever of unknown origin and was treated with chemotherapy and surgery, but ultimately experienced poor outcomes, including metastasis and additional paraneoplastic symptoms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!